These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22761129)

  • 1. Chronic cough as a complication of treatment with statins: a case report.
    Psaila M; Fsadni P; Montefort S
    Ther Adv Respir Dis; 2012 Aug; 6(4):243-6. PubMed ID: 22761129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
    Chen YW; Lai HW; Wang TD
    Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
    Zuccaro P; Mombelli G; Calabresi L; Baldassarre D; Palmi I; Sirtori CR
    Pharmacol Res; 2007 Apr; 55(4):310-7. PubMed ID: 17289397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
    Atasoyu EM; Evrenkaya TR; Solmazgul E
    Ann Pharmacother; 2005; 39(7-8):1368-9. PubMed ID: 15956236
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis after treatment with fluvastatin.
    Castiella A; Fernandez J; Zapata E
    Liver Int; 2007 May; 27(4):592. PubMed ID: 17403199
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.
    Baek SD; Jang SJ; Park SE; Ok TJ; Leem J; Lee HS; Park SJ; Kim TH
    J Korean Med Sci; 2011 Dec; 26(12):1634-7. PubMed ID: 22148003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statin-induced rhabdomyolysis and renal failure: also with fluvastatine].
    Lado Lado FL; Rodríguez Moreno C; Cinza Sajurjo S; Durán Parrondo C; Pazo Núñez M; Lois Pernas A; Masa Vázquez L
    An Med Interna; 2004 May; 21(5):235-7. PubMed ID: 15176926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
    Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal seizures after treatment with fluvastatin in a patient with a history of catastrophic antiphospholipid syndrome.
    Miesbach W; Chapman J; Scharrer I
    J Neurol Sci; 2005 Nov; 238(1-2):93-5. PubMed ID: 16111706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.
    Skottheim IB; Gedde-Dahl A; Hejazifar S; Hoel K; Asberg A
    Eur J Pharm Sci; 2008 Apr; 33(4-5):317-25. PubMed ID: 18294823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular adverse effects of statins.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602397
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.
    Li L; Ma Y; Geng XB; Song YX; Tan Z; Shang XM; Zhao GY; Zhao BQ; Tian MR
    Am J Ther; 2016; 23(1):e318-20. PubMed ID: 24451297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis induced by fluvastatin therapy.
    Tysk C; Al-Eryani AY; Shawabkeh AA
    J Clin Gastroenterol; 2002; 35(5):406-8. PubMed ID: 12394230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins.
    Krobot KJ; Wagner A; Siebert U
    Eur J Prev Cardiol; 2012 Feb; 19(1):109-17. PubMed ID: 21450620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
    Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not just decreased LDL level is decisive. Which statin for patients at risk for coronary disease?].
    MMW Fortschr Med; 2004 Jun; 146(24):1-3. PubMed ID: 15366507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.